%0 Journal Article
%T ATR小分子抑制剂的研究进展<br>Advances in the Study of Small Molecule Inhibitors of ATR
%A 程浩东
%A 段云鑫
%A 施志浩
%J Pharmacy Information
%P 138-156
%@ 2160-4452
%D 2023
%I Hans Publishing
%R 10.12677/PI.2023.122018
%X <span style=\"font-size:14px;\">共济失调毛细血管扩张和Rad3相关激酶(ATR)是DNA损伤反应(DDR)的重要调节因子，尤其是对复制压力(RS)的反应。由于DNA损伤和RS是基因组不稳定性的主要来源，选择性抑制ATR是癌症治疗的一种有前途的新方法。本文综述了ATR的结构功能以及ATR小分子抑制剂的研究进展，以求为此领域的进一步研究工作提供理论帮助和指导。</span><br />
<span style=\"font-size:14px;\">Ataxia-telangiectasia and Rad3-related kinase (ATR) are important regulators of the DNA damage response (DDR), particularly in response to replication stress (RS). As DDR and RS are major sources of genomic instability, selective inhibition of ATR is a promising new approach for cancer therapy. This article reviews the structural function of ATR and the progress of research on small molecule inhibitors of ATR in order to provide theoretical assistance and guidance for further research in this field.</span>
%K DNA损伤反应，ATR激酶，抑制剂，抗肿瘤<br>DNA Damage Response
%K ATR Kinase
%K Inhibitor
%K Antitumour
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=63704